Lehman David Aaron sold $5K of LUNG
Lehman David Aaron (GENERAL COUNSEL) sold 3,539 shares of Pulmonx Corp (LUNG) at $1.54 on 2026-06-01.
How this was made
The 30-second read
Why it matters
The disclosure provides incremental sentiment information but does not include new business, clinical, or financial results.
Market read
Traders may note the insider sale for sentiment/positioning, but it is unlikely to drive a major repricing absent other catalysts.
What to watch
No 10b5-1 plan is cited; however, absence of a plan detail alone is not sufficient to infer intent without additional filings or context.
Background
This is an SEC Form 4 insider transaction disclosure (officer/general counsel) for Pulmonx Corp.
Ticker impact
Pulmonx insider (general counsel) filed an open-market sale of 3,539 shares at $1.54 on 2026-06-01.
Likely small, short-lived negative bias; limited follow-through unless accompanied by other news.
The filing is a routine insider transaction with no 10b5-1 plan stated and no accompanying operational/financial disclosure, so impact is typically muted.
Market effects
Minimal; this is company-specific insider activity with no stated sector-wide signal.
None indicated.
None indicated.
Counterpoint
Insider sales can be routine for diversification/tax and do not necessarily reflect negative fundamentals.
Key entities
- issuerPulmonx Corp
Subject of the Form 4 insider sale; shares sold at $1.54 on 2026-06-01.
- insiderLehman David Aaron
General counsel who sold 3,539 shares (open-market sale).
